Suman Sen - Concepedia

Author

Suman Sen

Also Known As

Suman Sen

Publications

315

Citations

H-Index

Concepts

All Affiliations

Suman Sen is an author at AstraZeneca (United States) specializing in pharmacotherapy, cancer research, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	34
2	Health Sciences	1	1	11
3	Biochemistry	1	1	23
4	Biostatistics	1	1	11
5	Cell Biology	1	1	23

Suman Sen

Publications

310

Citations

H-Index

Page 1

	Year	Citations
Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors Jeffrey R. Infante, E. Claire Dees, Anthony J. Olszanski, Journal of Clinical Oncology	2014	205
CD22 Ligand Binding Regulates Normal and Malignant B Lymphocyte Survival In Vivo Karen M. Haas, Suman Sen, Isaac G. Sanford, The Journal of Immunology	2006	71
Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects Shyeilla V. Dhuria, Heidi J. Einolf, James B. Mangold, The Journal of Clinical Pharmacology Healthy SubjectsMidazolam CmaxApoptosisTime‐dependent InhibitionCell Death	2013	23
Accuracy and Safety of Novel Designs for Phase I Drug-Combination Oncology Trials Rong Liu, Ying Yuan, Suman Sen, Statistics in Biopharmaceutical Research PharmacotherapyMetronomic ChemotherapyMtd IdentificationOncologyClinical Trials	2022	11

Page 1